Get access

Increased risk of bladder cancer following diagnosis with bladder pain syndrome/interstitial cystitis

Authors

  • Joseph Keller,

    1. School of Public Health, Taipei Medical University, Taipei, Taiwan
    Search for more papers by this author
  • Hung-Yi Chiou,

    Corresponding author
    1. School of Public Health, Taipei Medical University, Taipei, Taiwan
    2. Center of Excellence for Cancer Research, Taipei Medical University, Taipei, Taiwan
    • School of Health Care Administration, Taipei Medical University, 250 Wu-Hsing St., Taipei 110, Taiwan.
    Search for more papers by this author
  • Herng-Ching Lin

    Corresponding author
    1. School of Health Care Administration, Taipei Medical University, Taipei, Taiwan
    • School of Health Care Administration, Taipei Medical University, 250 Wu-Hsing St., Taipei 110, Taiwan.
    Search for more papers by this author

  • Eric Rovner led the peer-review process as the Associate Editor responsible for the paper.

  • Conflicts of interest: none.

Abstract

Aims

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a prevalent disorder that may contribute to bladder cancer (BC). This cohort study set out to investigate the association between IC/BPS and BC by using a population-based dataset.

Methods

The data for this study were sourced from the Taiwan National Health Insurance program. The case cohort comprised 7,562 patients with IC/BPS, and 22,686 randomly selected subjects were used as a comparison cohort. A Cox proportional hazards regression model (stratified by age group, geographic location, urbanization level, and the index year) was constructed to estimate the risk of subsequent BC following a diagnosis of IC/BPS. We also ran the analysis utilizing an alternative comparison cohort composed of patients with urinary incontinence (UI).

Results

In the study sample of 30,248 patients, 96 patients (0.32%) received a diagnosis of BC during the 3-year follow-up period; 48 (0.63% of patients with IC/BPS) were from the study cohort; and 48 (0.21% of patients without IC/BPS) were from the comparison cohort. The incidence rate of BC was 2.12 (95% CI: 1.58–2.78) per 1,000 person-years in patients with IC/BPS and 0.70 (95% CI: 0.52–0.92) per 1,000 person-years in comparison patients. Cox proportional analysis revealed that the adjusted HR for BC during the 3-year follow-up period for patients with IC/BPS was 2.95 (95% CI: 1.97–4.41) that of comparison subjects. When performing the analysis with the alternative UI comparison cohort, the adjusted HR for BC was 1.96 (95% CI: 1.14–3.39).

Conclusions

This investigation detected a novel association between BC and prior IC/BPS. Neurourol. Urodynam. 32: 58–62, 2013. © 2012 Wiley Periodicals, Inc.

Get access to the full text of this article

Ancillary